BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 12, 2024

Total Value ($000): $4,709,988 (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 57.0%

Value ($000) $2,685,646 Shares 65,679,781 Est. Cost $18.73 Unrealized —

SGRY SURGERY PARTNERS INC 25.2%

Value ($000) $1,188,238 Shares 49,946,972 Est. Cost $31.75 Unrealized -19.2%

WAY WAYSTAR HLDG CORP 12.8%

Value ($000) $601,579 Shares 27,980,417 Est. Cost $21.67 Unrealized 0.0%

AVAH AVEANNA HEALTHCARE HLDGS INC 4.8%

Value ($000) $225,218 Shares 81,600,880 Est. Cost $11.86 Unrealized -79.0%

ADV ADVANTAGE SOLUTIONS INC 0.2%

Value ($000) $9,306 Shares 2,890,000 Est. Cost $10.52 Unrealized -64.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	65,679,781	$2,685,646	57.0%	$18.73	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	49,946,972	$1,188,238	25.2%	$31.75	-19.2%	COM	86881A100
WAY	WAYSTAR HLDG CORP	27,980,417	$601,579	12.8%	$21.67	0.0%	COM	946784105
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$225,218	4.8%	$11.86	-79.0%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$9,306	0.2%	$10.52	-64.6%	COM CL A	00791N102